Liver and biliary tract cancer trials in Hong Kong

In Hong Kong 17 Also abroad 1314

17 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Where
Hong Kong
Age
18 years and over
People
159
Run by
Chinese University of Hong Kong
See details and how to joinNCT07036874
Phase 1/2Taking people
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Where
Pokfulam, Shatin
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT06795022 · EU 2024-516698-56-00
Phase 3Taking people
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Where
Hong Kong
Age
18 years to 99 years
People
620 worldwide
Run by
AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00
Phase 3Taking people
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Where
Hong Kong
Age
18 years and over
People
1,220 worldwide
Run by
AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00
No phaseTaking people
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
Where
Hong Kong
Age
18 years to 80 years
People
30
Run by
The University of Hong Kong
See details and how to joinNCT07305428
No phaseTaking people
Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence
Where
Hong Kong
Age
18 years and over
People
20
Run by
The University of Hong Kong
See details and how to joinNCT07839767
Phase 2Taking people
Phase 2 Study of WGI-0301 for Advanced HCC
Where
Hong Kong
Age
18 years and over
People
60 worldwide
Run by
Zhejiang Haichang Biotech Co., Ltd.
See details and how to joinNCT06309485
Phase 2Taking people
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Where
Hong Kong Island, New Territories
Age
18 years and over
People
120 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00
Phase 1/2Taking people
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Where
Hong Kong
Age
18 years and over
People
180 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00
No phaseTaking people
SBRT in HCC With Oligoprogression on First-line Immunotherapy
Where
Hong Kong
Age
18 years and over
People
30
Run by
Chinese University of Hong Kong
See details and how to joinNCT06434480
Phase 2/3Taking people
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Where
Hong Kong
Age
18 years to 80 years
People
106
Run by
Tuen Mun Hospital
See details and how to joinNCT07293468
No phaseTaking people
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients
Where
Shatin
Age
18 years and over
People
84
Run by
Chinese University of Hong Kong
See details and how to joinNCT05629845
No phaseTaking people
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
Where
Hong Kong
Age
18 years to 100 years
People
40
Run by
Chinese University of Hong Kong
See details and how to joinNCT06077591
No phaseTaking people
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Where
Hong Kong
Age
18 years and over
People
15
Run by
Chinese University of Hong Kong
See details and how to joinNCT06885879
No phaseTaking people
The Overall Survival of Patients With Unresectable HCC in Real-life
Where
Hong Kong
Age
18 years and over
People
5,000 worldwide
Run by
Humanity & Health Medical Group Limited
See details and how to joinNCT03612726
Phase 2Taking people
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Where
Hong Kong
Age
18 years and over
People
30
Run by
Humanity & Health Medical Group Limited
See details and how to joinNCT03899428
Phase 1/2Taking people
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Where
Hong Kong
Age
18 years to 70 years
People
46 worldwide
Run by
SCG Cell Therapy Pte. Ltd.
See details and how to joinNCT05417932